Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 1, 2016
Pharmacy Choice - News - Front Page Healthcare News - May 1, 2016

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/1/16 - Cempra Completes NDA Submissions for Solithromycin in the Treatment of Community-Acquired Bacterial Pneumonia
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced the completion of its rolling submission of the New Drug Applications for solithromycin to the U.S. Food and Drug Administration for the treatment of...
5/1/16 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 12511) - Workshop
EVENT: Health and Human Services Department; Food and Drug Administration holds a workshop entitled "Mass Spectrometry in the Clinic: Regulatory Considerations Surrounding Validation of Liquid Chromatography-Mass Spectrometry Based Devices," focusing on the specific analytical and clinical study designs and considerations for validation and use of.
5/1/16 - Hospital execs: Fees, not cuts, are best way to fund Medicaid [The Santa Fe New Mexican]
May 01 It's likely New Mexico now leads the country in yet another measure of distress: the percent of its population receiving health insurance under Medicaid. While the enrollment surge means far fewer state residents are going without health care coverage, New Mexico is facing an expected shortfall of about $85 million to fully fund its Medica
5/1/16 - Hospital execs: Fees, not cuts, are best way to help Medicaid [The Santa Fe New Mexican]
May 01 It's likely New Mexico now leads the country in yet another measure of distress: the percent of its population receiving health insurance under Medicaid. While the enrollment surge means far fewer state residents are going without health care coverage, New Mexico is facing an expected shortfall of about $85 million to fully fund its Medica
5/1/16 - Kidney stone patients hospitalized on the weekend may get delayed treatment
By a News Reporter-Staff News Editor at VerticalNews Health& Science MAYWOOD, IL.- Patients with severe cases of kidney stones are 26 percent less likely to receive timely treatment when they're admitted to the hospital on the weekend, according to a study by researchers at Loyola Medicine and Loyola University Chicago Stritch School of Medicine.
5/1/16 - New Kawasaki Disease Findings Has Been Reported by Investigators at General Hospital (Progressive Coronary Dilatation Predicts Worse Outcome in...
New Kawasaki Disease Findings Has Been Reported by Investigators at General Hospital. By a News Reporter-Staff News Editor at Heart Disease Weekly Investigators publish new report on Kawasaki disease. According to news reporting from Taipei, Taiwan, by NewsRx journalists, research stated, "To explore the implication of serial coronary changes on
5/1/16 - New report identifies 6 practices to improve health care for disadvantaged populations
By a News Reporter-Staff News Editor at VerticalNews Health WASHINGTON- A new report from the National Academies of Sciences, Engineering, and Medicine identifies six promising practices to improve health care for individuals with social risk factors for poor health care outcomes, such as people who are in a low socio-economic position, reside in
5/1/16 - New York PPACA exchange seeks 2017 plans [LifeHealthPro]
The public exchange managers in New York state may already know roughly how many issuers they can hope to have on the menu in 2017.. The New York exchange market suffered a blow in September 2015, when state and federal regulators announced that Health Republic Insurance Company of New York would shut down at the end of November. NY State of Health
5/1/16 - Physicians' knowledge about FDA approval standards for 'breakthrough therapy'
By a News Reporter-Staff News Editor at VerticalNews Health In a study appearing in the April 12 issue of JAMA, Aaron S. Kesselheim, M.D., J.D., M.P.H., of Brigham and Women's Hospital, Boston, and colleagues surveyed internists and specialists to examine their knowledge about Food and Drug Administration approval standards and perceptions of the
4/30/16 - Attorney Joe Garza: Attacks on Corporations May Hurt American Citizens
By a News Reporter-Staff News Editor at Marketing Weekly News The U.S. Treasury Department took another well-aimed blow at the pharmaceutical industry on Monday night when it announced significant measures to curb the use of "tax inversions." But making things harder on U.S. corporations doesn't help ordinary citizens all that much. "U.S. corpor
4/30/16 - Belgium : Involving general practitioners in regulatory decisions on medicines [TendersInfo (India)]
The European Medicines Agency organised a workshop with representatives of general practitioners and family doctors in order to explore new ways to engage with these providers of primary care in EU Member States and further involve them in EMA activities. General practitioners and family physicians play a key role in patient care; they often have t
4/30/16 - Capitol Roundup: PA Department of Human Services awards landmark Medicaid agreements
WILKES-BARRE Pennsylvania Department of Human Services Secretary Ted Dallas announced last week the state has agreed to move forward and negotiate contracts with eight managed care organizations to deliver physical health services to Pennsylvanians through HealthChoices, Pennsylvania s mandatory Medicaid managed care program since 1997..
4/30/16 - CHMP Issues Positive Opinion to Include New Data in European Label for XTANDI enzalutamide
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Astellas Pharma Inc. and Medivation, Inc. announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending approval of a type II variation to include data from the head-to-head TERRAIN trial of enzal
4/30/16 - CNOGA Receives CFDA Approval for Marketing in China of Non Invasive Multiple Bio Parameters Monitors
By a News Reporter-Staff News Editor at Marketing Weekly News CNOGA Medical Ltd., a developer and manufacturer of medical devices, announces that it has received an approval for its TensorTip? MTX? and VSM? non-invasive multiple bio parameters measurement devices from the China Food and Drug Administration. Dr. Segman added; " China is the
4/30/16 - Ireland,United Kingdom : Medtronic Demonstrates Commitment to EVAR in Comparison Study of ENGAGE Global Registry and Landmark EVAR 1 Trial [TendersInfo (India)]
Medtronic plc today reported on the ENGAGE global registry of experiences with the Endurant AAA stent graft system from Medtronic with a reference to the landmark EVAR 1 Trial. Professor Roger Greenhalgh, M.D., Charing Cross chairman and author of the EVAR 1 Trial stated, "The EVAR 1 trial is the world's first randomized, controlled trial of EVAR c
4/30/16 - Stereotaxis Awarded U.S. Patent for Vmotion Spotlight Automation Feature of Vdrive Robotic Navigation System [Qatar Tribune]
-Stereotaxis, Inc., a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 9,314,222 titled, Operation of a Remote Medical Navigation System Using Ultrasound Image. This patent represents another important step in the expansion of our prop
4/30/16 - The Tinnitus Toolbox Guide to Support the Full Patient Journey
Hearing care professionals need to be able to recognize which tools in their tinnitus toolbox to utilize on a patient-by-patient basis, and also to be aware of research, to help make navigation of the treatment process easier for both clinician and patient.
4/30/16 - United States : FDA approves first generic Crestor [TendersInfo (India)]
The FDA is working hard to get first-time generic drugs approved as quickly as possible so patients can have increased access to needed treatments, said Kathleen Uhl, M.D., director of the Office of Generic Drugs in the FDAs Center for Drug Evaluation and Research. The FDA requires that generic drugs meet rigorous scientific and quality standards.
4/30/16 - United States : Smart Technologies for Continuous Patient Monitoring to Assist Hospital Staff in At-Risk Situations and Grow Hospital Revenues [TendersInfo (India)]
Contact-free continuous patient monitoring technology allows a facility to effectively monitor every patient bed, and constantly monitor a patients status without having to connect cables, leads and sensors to the individual. A new whitepaper from Frost& Sullivan, Finding Top-Line Opportunities in a Bottom-Line Healthcare Market, determines CFCM sm
4/30/16 - USW says new contract preserves pay and benefits [The Times, Munster, Ind.]
April 30 About 9,500 ArcelorMittal steelworkers in Northwest Indiana won't get a pay raise over the next three years under a proposed contract, but the United Steelworkers union said it preserves wages and benefits, including no premiums for health insurance. ArcelorMittal wanted to slash costs after losing $8 billion last year, including by slas
4/29/16 - Advanced Accelerator Applications reports 26.8% sales growth in 2015 and continues to show significant clinical progress across both therapeutic and diagnostic platforms
Stefano Buono, AAA s CEO, commented, 2015 was a pivotal year for AAA. We also submitted an NDA and MAA in the U.S. and Europe, respectively, for Somakit, which could be the ideal in-vivo companion diagnostic for Lutathera.. With our Lutathera filing now complete and submitted to the FDA and the EMA and the anticipated Somakit approval in b
4/29/16 - Aetna: Saving the PPACA exchange system is a good investment [LifeHealthPro]
Executives from Aetna Inc. today gave only general information about the company's current public health insurance exchange operations, said nothing about 2017 exchange plan menus, and called for policymakers in Washington to help them revamp the system. See also: Democrats evenly split over Clinton, Sanders in Bloomberg poll. Executives from Cente
4/29/16 - Agrilabs Expands U.S. Animal Health Marketing and Distribution Business [Tripoli Post, The (Libya)]
AgriLabs, the largest U.S. animal health marketing and distribution business, announced that it has entered into the vaccine manufacturing business with a new USDA- licensed facility in Lincoln, Nebraska. By adding state-of-the-art manufacturing capabilities to our U.S. marketing and sales operations, we can deliver more value to veterinarians and.
4/29/16 - Allergan Reinforces Commitment to Anti-Infective Innovation with 20 Abstracts Highlighted at ECCMID 2016
By a News Reporter-Staff News Editor at Drug Week Allergan plc, a leading global pharmaceutical company committed to developing new treatment options for infectious diseases, announced that new data from its anti-infective portfolio will be featured in 20 abstracts during the upcoming European Congress of Clinical Microbiology and Infectious...
4/29/16 - AstraZeneca: CHMP Issues Positive Opinion For CAZ AVI
LONDON- British drug maker AstraZeneca plc said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency has issued a positive opinion, recommending the approval of a new antibiotic, CAZ AVI 2 g/0. 5 g powder. CAZ AVI is being jointly developed by AstraZeneca and Allergan plc to treat a broad range of Gram-ne
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415